Effectiveness was assessed by evaluating the percentage of study participants tolerating an oral challenge with a single 600 mg dose of peanut protein (twice the daily maintenance dose of arachis hypogaea allergen powder) with no more than mild allergic symptoms after 6 months of maintenance treatment.